106 related articles for article (PubMed ID: 2418287)
1. AQ-AH 208, a new bradycardic agent, increases coronary collateral blood flow to ischemic myocardium.
Daemmgen JW; Gross GJ
J Cardiovasc Pharmacol; 1985; 7(6):1048-54. PubMed ID: 2418287
[TBL] [Abstract][Full Text] [Related]
2. Effects of AQ-AH 208, a new specific bradycardic agent, on myocardial ischemia-reperfusion injury in anesthetized dogs.
Gross GJ; Warltier DC; Daemmgen JW
J Cardiovasc Pharmacol; 1985; 7(5):929-36. PubMed ID: 2413303
[TBL] [Abstract][Full Text] [Related]
3. Actions of two new bradycardic agents, AQ-AH 208 and UL-FS 49, on ischemic myocardial perfusion and function.
Dämmgen JW; Lamping KA; Gross GJ
J Cardiovasc Pharmacol; 1985; 7(1):71-9. PubMed ID: 2580154
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of two specific bradycardic agents AQ-A39 (falipamil) and AQ-AH 208 on reversible myocardial reperfusion damage in anesthetized dogs.
Gross GJ; Daemmgen JW
J Pharmacol Exp Ther; 1986 Aug; 238(2):422-8. PubMed ID: 3735124
[TBL] [Abstract][Full Text] [Related]
5. Effects of bradycardic agents on ischaemic myocardium and perfusion in anesthetized dogs.
Gross GJ; Daemmgen JW
Eur Heart J; 1987 Dec; 8 Suppl L():69-74. PubMed ID: 3451885
[TBL] [Abstract][Full Text] [Related]
6. Effect of the new specific bradycardia agent AQ-A39 (falipamil) on coronary collateral blood flow in dogs.
Gross GJ; Daemmgen JW
J Cardiovasc Pharmacol; 1987 Jul; 10(1):123-7. PubMed ID: 2441148
[TBL] [Abstract][Full Text] [Related]
7. AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart.
Kobinger W; Lillie C
Eur J Pharmacol; 1981 Jun; 72(2-3):153-64. PubMed ID: 7250205
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular actions of 5,6-dimethoxy-2-(3-[(alpha-(3,4-dimethoxy) phenylethyl)-methylamino] propyl) phthalimidine (AQ-A 39), a specific bradycardic agent.
Dämmgen J; Kadatz R; Diederen W
Arzneimittelforschung; 1981; 31(4):666-70. PubMed ID: 7195712
[TBL] [Abstract][Full Text] [Related]
9. Effect of beta-adrenergic suppression by propranolol on coronary collateral development in response to chronic coronary ischemia in dogs.
Neill WA; Nakornchai V; Oxendine J; Paul MS
Circulation; 1979 Feb; 59(2):280-5. PubMed ID: 215339
[TBL] [Abstract][Full Text] [Related]
10. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
Kawada M; Satoh K; Taira N
J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
[TBL] [Abstract][Full Text] [Related]
11. Beneficial actions of N-dimethyl propranolol on myocardial oxygen balance and transmural perfusion gradients distal to a severe coronary artery stenosis in the canine heart.
Gross GJ; Warltier DC; Hardman HF
Circulation; 1978 Oct; 58(4):663-9. PubMed ID: 688577
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
Kobinger W; Lillie C
Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular responses to increasing plasma concentrations of AQ-A 39 Cl, a new compound with negative chronotropic effects.
Verdouw PD; Bom HP; Bijleveld RE
Arzneimittelforschung; 1983; 33(5):702-6. PubMed ID: 6683548
[TBL] [Abstract][Full Text] [Related]
14. Influence of desflurane on regional distribution of coronary blood flow in a chronically instrumented canine model of multivessel coronary artery obstruction.
Hartman JC; Pagel PS; Kampine JP; Schmeling WT; Warltier DC
Anesth Analg; 1991 Mar; 72(3):289-99. PubMed ID: 1994756
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cardiovascular responses to the bradycardic drugs, alinidine, AQ-A 39, and mixidine, in the anesthetized dog.
Siegl PK; Wenger HC; Sweet CS
J Cardiovasc Pharmacol; 1984; 6(4):565-74. PubMed ID: 6206308
[TBL] [Abstract][Full Text] [Related]
16. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
[TBL] [Abstract][Full Text] [Related]
17. Effects of three bradycardiac drugs on regional myocardial blood flow and function in areas distal to a total or partial coronary occlusion in dogs.
Gross GJ; Lamping KG; Warltier DC; Hardman HF
Circulation; 1984 Feb; 69(2):391-9. PubMed ID: 6690105
[TBL] [Abstract][Full Text] [Related]
18. Effect of halothane on coronary collateral circulation.
Sivarajan M; Bashein G
Anesthesiology; 1985 May; 62(5):588-96. PubMed ID: 3994024
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of a new nicotinamide nitrate derivative, nicorandil (SG 75), with nifedipine and nitroglycerin on true collateral blood flow following an acute coronary occlusion in dogs.
Lamping KA; Gross GJ
J Cardiovasc Pharmacol; 1984; 6(4):601-8. PubMed ID: 6206313
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of pharmacologic vasodilation on true collateral and overlap perfusion in ischemic myocardium.
Keelan KE; Gross GJ; Brooks HL; Warltier DC
Gen Pharmacol; 1984; 15(6):471-7. PubMed ID: 6526259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
